Cargando…

Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data

INTRODUCTION: In general, racial and ethnic differences exist in antipsychotic prescription practices. However, little is known about such differences between individual long-acting injectable (LAI) antipsychotic formulations, specifically. This study's primary objective was to determine racial...

Descripción completa

Detalles Bibliográficos
Autores principales: Caballero, Joshua, Xu, Jianing, Hall, Daniel B., Chen, Xianyan, Young, Henry N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Psychiatric Pharmacists 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583257/
https://www.ncbi.nlm.nih.gov/pubmed/37860586
http://dx.doi.org/10.9740/mhc.2023.08.183
_version_ 1785122512549445632
author Caballero, Joshua
Xu, Jianing
Hall, Daniel B.
Chen, Xianyan
Young, Henry N.
author_facet Caballero, Joshua
Xu, Jianing
Hall, Daniel B.
Chen, Xianyan
Young, Henry N.
author_sort Caballero, Joshua
collection PubMed
description INTRODUCTION: In general, racial and ethnic differences exist in antipsychotic prescription practices. However, little is known about such differences between individual long-acting injectable (LAI) antipsychotic formulations, specifically. This study's primary objective was to determine racial and ethnic differences among LAI antipsychotic use. Secondary objectives were to identify if discontinuation rates differed between agents and by race or ethnicity. METHODS: International Classification of Diseases, 10th edition (ICD-10) codes were used to identify patients with schizophrenia and related disorders (18-64 years) who received an LAI antipsychotic between 2016 and 2020 using Merative Multi-State Medicaid databases. Using National Drug Code numbers for LAI antipsychotics, pharmacy claims were identified and data analyzed. Cochran-Mantel-Haenszel tests and odds ratio estimators were used to investigate conditional association between race or ethnicity and medication, while controlling for age, sex, health plan, and prescription year. Kaplan-Meier survival curves were examined, and stratified log-rank tests were conducted to compare the time until discontinuation distributions by race or ethnicity. RESULTS: The analysis included 37 712 patients. Blacks received an LAI first-generation antipsychotic more often than Whites (OR: 1.64, 95% CI: [1.56, 1.73], Hispanics (OR: 1.46, 95% CI: [1.21, 1.75]) and others (OR: 1.44, 95% CI: [1.20, 1.73]). Aside from fluphenazine decanoate showing earlier discontinuation rates for Whites over Blacks (P = .02), no significant differences in discontinuation across race or ethnicity were identified. DISCUSSION: Despite no significant differences in second-generation antipsychotic LAI discontinuation rates between Blacks and other racial or ethnic groups, Blacks received second-generation antipsychotic LAIs significantly less often than other groups. Further studies are needed to determine why differences may be occurring.
format Online
Article
Text
id pubmed-10583257
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association of Psychiatric Pharmacists
record_format MEDLINE/PubMed
spelling pubmed-105832572023-10-19 Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data Caballero, Joshua Xu, Jianing Hall, Daniel B. Chen, Xianyan Young, Henry N. Ment Health Clin Original Research INTRODUCTION: In general, racial and ethnic differences exist in antipsychotic prescription practices. However, little is known about such differences between individual long-acting injectable (LAI) antipsychotic formulations, specifically. This study's primary objective was to determine racial and ethnic differences among LAI antipsychotic use. Secondary objectives were to identify if discontinuation rates differed between agents and by race or ethnicity. METHODS: International Classification of Diseases, 10th edition (ICD-10) codes were used to identify patients with schizophrenia and related disorders (18-64 years) who received an LAI antipsychotic between 2016 and 2020 using Merative Multi-State Medicaid databases. Using National Drug Code numbers for LAI antipsychotics, pharmacy claims were identified and data analyzed. Cochran-Mantel-Haenszel tests and odds ratio estimators were used to investigate conditional association between race or ethnicity and medication, while controlling for age, sex, health plan, and prescription year. Kaplan-Meier survival curves were examined, and stratified log-rank tests were conducted to compare the time until discontinuation distributions by race or ethnicity. RESULTS: The analysis included 37 712 patients. Blacks received an LAI first-generation antipsychotic more often than Whites (OR: 1.64, 95% CI: [1.56, 1.73], Hispanics (OR: 1.46, 95% CI: [1.21, 1.75]) and others (OR: 1.44, 95% CI: [1.20, 1.73]). Aside from fluphenazine decanoate showing earlier discontinuation rates for Whites over Blacks (P = .02), no significant differences in discontinuation across race or ethnicity were identified. DISCUSSION: Despite no significant differences in second-generation antipsychotic LAI discontinuation rates between Blacks and other racial or ethnic groups, Blacks received second-generation antipsychotic LAIs significantly less often than other groups. Further studies are needed to determine why differences may be occurring. American Association of Psychiatric Pharmacists 2023-08-07 /pmc/articles/PMC10583257/ /pubmed/37860586 http://dx.doi.org/10.9740/mhc.2023.08.183 Text en © 2023 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists. https://creativecommons.org/licenses/by-nc/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Caballero, Joshua
Xu, Jianing
Hall, Daniel B.
Chen, Xianyan
Young, Henry N.
Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data
title Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data
title_full Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data
title_fullStr Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data
title_full_unstemmed Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data
title_short Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data
title_sort racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using medicaid claims data
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583257/
https://www.ncbi.nlm.nih.gov/pubmed/37860586
http://dx.doi.org/10.9740/mhc.2023.08.183
work_keys_str_mv AT caballerojoshua racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata
AT xujianing racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata
AT halldanielb racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata
AT chenxianyan racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata
AT younghenryn racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata